J B Chemicals & Pharmaceuticals Ltd. - Research Center
506943 JBCHEPHARM Group (A) BSE data
Results
Statement
More
Mar ' 24 |
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Equity share capital
15.52 |
15.48 |
15.46 |
15.46 |
15.46 |
Share application money
Preference share capital
Reserves & surplus
2,870.74 |
2,305.38 |
2,025.56 |
1,791.00 |
1,429.83 |
Secured loans
341.80 |
526.93 |
26.32 |
26.43 |
32.04 |
Unsecured loans
Total
3,228.06 |
2,969.41 |
2,129.98 |
1,832.89 |
1,477.33 |
Gross block
2,595.81 |
2,444.24 |
1,773.44 |
1,097.48 |
1,094.50 |
Less : revaluation reserve
Less : accumulated depreciation
670.39 |
622.58 |
569.77 |
532.88 |
511.29 |
Net block
1,925.42 |
1,821.66 |
1,203.67 |
564.60 |
583.21 |
Capital work-in-progress
76.06 |
55.15 |
18.68 |
25.57 |
16.17 |
Investments
531.23 |
338.94 |
145.69 |
810.85 |
536.23 |
Current assets, loans & advances
1,380.92 |
1,254.40 |
1,170.04 |
799.41 |
675.41 |
Less : current liabilities & provisions
685.58 |
500.74 |
408.08 |
367.54 |
333.69 |
Total net current assets
695.34 |
753.66 |
761.95 |
431.87 |
341.72 |
Miscellaneous expenses not written
Total
3,228.06 |
2,969.41 |
2,129.98 |
1,832.89 |
1,477.33 |
Book value of unquoted investments
166.58 |
146.75 |
145.69 |
145.88 |
145.85 |
Market value of quoted investments
Contingent liabilities
1,110.90 |
120.63 |
68.13 |
117.00 |
121.66 |
Number of equity sharesoutstanding (Lacs)
1551.95 |
773.78 |
772.82 |
772.82 |
772.82 |